Table 8.

Percent of oropharyngeal swallowing disorders observed in the 11 patients with laryngeal cancer treated with chemoradiation at pretreatment (baseline) and 3 and 12 mo posttreatment.

	Baseline, %	Posttreatment		Overall p value by Cochran's Q	Pairwise p value by McNemar's
		3 mo, %	12 mo, %		Baseline vs 3 mo	Baseline vs 12 mo	3 vs 12 mo
Description of disorder
Reduced tongue base retraction	55	82	91	.039	.08	.05	.32
Reduced tongue strength	45	64	36	.31	.32	.56	.18
Delayed pharyngeal swallow	36	45	36	.85	.56	.99	.56
Slowed/delayed vestibule closure	18	55	55	.14	.10	.05	.99
Reduced tongue control	27	27	36	.78	.99	.56	.56
Reduced A-P tongue movement	0	45	64	.008	No test	No test	.32
Reduced laryngeal elevation	36	55	55	.51	.32	.32	.99
Reduced tongue stabilization	0	9	9	.61	No test	No test	.99
Bilateral pharyngeal weakness	0	45	27	.07	No test	No test	.41
Reduced cricopharyngeal opening	0	36	36	.041	No test	No test	.99
Visible cricopharyngeal bar	9	0	9	.61	No test	.99	No test
Incomplete laryngeal vestibule closure	9	18	18	.72	.32	.56	.99
Other measures of swallowing
Functional swallow	100	73	73	No test	No test	No test	No test
% Oral intake <50%	0	36	18	.050	No test	No test	.16
% Normal diet	55	18	45	.16	.10	.65	.083
Mean saliva weight (in grams)	6.40	1.25	1.46	<.001	<.001	<.001	.74
SEM	1.02	0.44	0.44

Abbreviations: SEM, standard error of the mean; A-P, anterior-posterior.

Note: Bolded values indicate p < .05 for overall test or p < .017 for pairwise test. (“No test” means frequencies were too low to perform statistical tests).